Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug

Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.

Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development

To enable company to be future-ready by tapping potential in CDMO space

Calibre Chemicals takes over R&D activities of Tina Life Sciences

Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.

Thermo Fisher Scientific expands its capabilities in France

Bourgoin early development hub broadens offerings for oral solid dose formulations

AIIA to host a Working Group of C20 on Integrated Holistic Health

The C20 is an engagement group of the G20 that focuses on Civil issues and looks to promote sustainable growth and financial stability.

mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma

Approx 800 million Indians do not have health coverage, says Expert

Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand

AnaBios acquires Cell Systems to expand human cell portfolio for drug discovery

Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections

Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039

Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product

Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution